B Cell Responses in COVID-19

B Cell Responses in COVID-19: Generation of SARS-CoV-2 Neutralizing Human Monoclonal Antibodies to Efficiently Contrast Wild-type and Emerging Variants.

In this study, we will develop techniques to optimize the in vitro production of human monoclonal antibodies.

Inclusion Criteria:

• Age >18 at time of signing informed consent form
• Signed informed consent form

Exclusion Criteria:

• Ongoing drug abuse
• Active or history of neoplastic malignancy
• Active autoimmune disease ongoing treatment with immunosuppressive therapy
• Ischemic heart disease
• Evidence of positive HIV, HCV, HBV test
• Diabetes
• Failure to sign informed consent form